Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amarin (AMRN – Research Report), Johnson & Johnson (JNJ – Research Report) and UnitedHealth (UNH – Research Report). Amarin (AMRN) In a report released today, Roanna Ruiz from SVB Securities maintained a Hold rating on Amarin, with a price target of $2.00. The company's shares closed last Tuesday at $1.17, close to its 52-week low of $1.04. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amarin-amrn-johnson-johnson-jnj-and-unitedhealth-unh?utm_source=advfn.com&utm_medium=referral